FDA Grants De Novo Request for Neuromodulatory System for Urge Incontinence
The FDA has granted a de novo marketing request for the Revi System for tibial neuromodulation to treat urinary incontinence with or without urinary urgency, BlueWind Medical announced on Thursday. The de novo request allows for treatment of men and women with urge urinary incontinence (UUI). Clinicians should follow applicable clinical guidelines and use professional […]
Neuromodulation of the Peroneal Nerve Safe for Overactive Bladder
Electrical transcutaneous neuromodulation (eTNM) of the peroneal nerve led to fewer side effects compared with solifenacin (Vesicare) in the treatment of overactive bladder, a randomized trial showed. Among 76 treatment-naive women randomized 2:1 to peroneal eTNM or solifenacin, 12% versus 48% reported a treatment-related adverse event (TRAE; P<0.001), reported Jan Krhut, MD, PhD, of University […]
Sacral Neuromodulation Promising in Neurogenic Lower Urinary Dysfunction
Sacral neuromodulation (SNM) is effective — at least in the short term — for patients with a type of urinary tract dysfunction, according to Swiss investigators. In a sham-controlled, double-blind study, 60 eligible patients with neurogenic lower urinary tract dysfunction (NLUTD) — i.e., with urgency frequency syndrome, urgency incontinence, or chronic urinary retention — had […]